About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Gynecologic Oncology
›
Top Articles
Gynecologic Oncology
Gynaecology
,
Oncology
4.9
(top 10%)
Impact Factor
5.3
(top 10%)
extended IF
182
(top 1%)
H-Index
4.2K
authors
15.2K
papers
478.8K
citations
8K
citing journals
81.5K
citing authors
Most Cited Articles of Gynecologic Oncology
Title
Year
Citations
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
2008
1.9K
Two pathogenetic types of endometrial carcinoma
1983
1.6K
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
2004
1.3K
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study
1991
1.1K
A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study
1999
861
Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
1990
730
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging
2008
601
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
2009
557
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
2009
536
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study
2000
530
Uterine sarcomas: a review
2010
518
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
2008
506
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
2006
466
Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling
1995
453
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study
1992
440
Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model
1992
419
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study
1998
417
Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model
1995
415
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy
1989
413
Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice
1992
406
Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999
2004
400
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
2009
399
Uterine papillary serous carcinoma: patterns of metastatic spread
1994
389
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis
2012
383
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva
1990
353
previous
2004
2005
2006
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.